Suchergebnisse - "Chen, Jianhua"

PubPharm (22)

1

Neoadjuvant Camrelizumab for Non-Small Cell Lung Cancer : A Retrospective Multicenter, Real-World Study (CTONG2004)

enthalten in: Cancer immunology, immunotherapy : CII | 2023

von Liu, S. | Chen, Q. | Zhou, C. | +11

2

Efficacy and safety of iruplinalkib (WX-0593) in ALK-positive crizotinib-resistant advanced non-small cell lung cancer patients : a single-arm, multicenter phase II study (INTELLECT)

enthalten in: BMC medicine | 2023

von Shi, Y. | Chen, J. | Zhang, H. | +30

3

Efficacy and Safety of SH-1028 in Patients With EGFR T790M-Positive NSCLC : A Multicenter, Single-Arm, Open-Label, Phase 2 Trial

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2022

von Xiong, A. | Ren, S. | Liu, H. | +34

4

Safety and activity of WX-0593 (Iruplinalkib) in patients with ALK- or ROS1-rearranged advanced non-small cell lung cancer : a phase 1 dose-escalation and dose-expansion trial

enthalten in: Signal transduction and targeted therapy | 2022

von Shi, Y. | Fang, J. | Hao, X. | +26

5

Safety but Limited Efficacy of Ensartinib in ROS1-Positive NSCLC : A Single-Arm, Multicenter Phase 2 Study

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2021

von Ai, X. | Wang, Q. | Cheng, Y. | +21

6

Decoding the Evolutionary Response to Ensartinib in Patients With ALK-Positive NSCLC by Dynamic Circulating Tumor DNA Sequencing

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2021

von Yang, Y. | Huang, J. | Wang, T. | +41

7

Dose escalation and expansion (phase Ia/Ib) study of GLS-010, a recombinant fully human antiprogrammed death-1 monoclonal antibody for advanced solid tumors or lymphoma

enthalten in: European journal of cancer (Oxford, England : 1990) | 2021

von Liu, D. | Ma, C. | Lu, P. | +35

8

Acute psychological impact of coronavirus disease 2019 outbreak among psychiatric professionals in China : a multicentre, cross-sectional, web-based study

enthalten in: BMJ open | 2021

von Guo, X. | McCutcheon, R. | Pillinger, T. | +8

9

Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL) : a randomised, open-label, multicentre, phase 3 trial

enthalten in: The Lancet. Respiratory medicine | 2021

von Zhou, C. | Chen, G. | Huang, Y. | +34

10

Efficacy and Biomarker Analysis of Camrelizumab in Combination with Apatinib in Patients with Advanced Nonsquamous NSCLC Previously Treated with Chemotherapy

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2021

von Zhou, C. | Wang, Y. | Zhao, J. | +23